During the past decade, Alliance for Multispecialty Research, LLC conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 5 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 5 clinical trials were completed. i.e. 23.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alliance for Multispecialty Research, LLC" #1 sponsor was "Pfizer" with 8 trials, followed by "BioNTech SE" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Unity Biotechnology, Inc." with 2 trials sponsored and "Achieve Life Sciences" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alliance for Multispecialty Research, LLC" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "JPEO, Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)" with 1 trials as a collaborator and "OSTAtistics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Alliance for Multispecialty Research, LLC" are "Migraine" (4 trials), "COVID-19" (3 trials), "Influenza, Human" (2 trials), "Osteoarthritis, Knee" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "Alliance for Multispecialty Research, LLC" in a lesser frequency.

Most popular intervention types in "Alliance for Multispecialty Research, LLC" are "Biological" (12 trials), "Drug" (10 trials), "Other" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "BNT162b2" (2 trials), "Lasmiditan" (2 trials), "BHV-3500 (zavegepant)" (1 trials) and "BNT162b1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alliance for Multispecialty Research, LLC" are 20 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Alliance for Multispecialty Research, LLC". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Alliance for Multispecialty Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alliance for Multispecialty Research, LLC, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".